Skip to content

Effect of Dietary Fiber on Glucose & Lipids in Non Insulin Dependent Diabetes Mellitus (NIDDM)

Effect of Dietary Fiber on Glucose, Lipid, and Mineral Metabolism in Patients With Non Insulin Dependent Diabetes Mellitus

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00825383
Enrollment
13
Registered
2009-01-21
Start date
1993-01-31
Completion date
1995-12-31
Last updated
2013-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Insulin-Dependent Diabetes Mellitus

Keywords

Diabetes, lipids, fiber

Brief summary

Effect of Dietary Fiber on glucose, lipid, and mineral metabolism in patients with non insulin dependent diabetes mellitus.

Detailed description

Two diets will be compared,a low fiber diet and a high fiber diet. These two diets will differ only in the content of total dietray fiber derived from natural food products. The diets will be identical in terms of total energy, percentage of total energy as proteins, fat and carbohydrates.

Interventions

OTHERHigh Fiber and Moderate Fiber Diets

Dietary

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* NIDDM * age 35 to 80 years * stable oral hypoglycemic treatment for at least one month * fasting triglycerides \< 500 mg/dl

Exclusion criteria

* insulin dependent NIDDM * insulin dependent diabetes * hepatic disease * significant hepatic dysfunction * signifiacnt renal dysfunction * presence of significant hematological, neurological, cardiovascular or gastrointestinal disorder, unless stable for past 6 months, * serious intercurrent illness or anticipated major surgery * female pregnant or likely to become pregnant * chronic drug abuse, alcoholism or psychaitric disorder within the past 2 years * treated with beta adrenergic blockers * on lipid lowering drugs

Design outcomes

Primary

MeasureTime frame
glucose and lipid metabolismBaseline and during the last 5 days of each 6 week dietary phase

Secondary

MeasureTime frame
calcium isotope absorption in the gastrointestinal tract, stool mineral content, 24 h urinary mineral concentration, and serum chemistry including mineral concentration.Baseline and during the last 5 days of each 6 week dietary phase

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026